Additionally, the significantly increased levels of NOTCH1 in RET+ tumors might partially explain the higher rates of extrathoracic metastases in RET+ compared to ROS1+ NSCLC patients. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.